Showing results (21-30 of 44) with videos related to
Sort By:
Pageof 5
Molecules (Basel, Switzerland)|June 2, 2021
New Coumarin Derivatives as Cholinergic and Cannabinoid System ModulatorsSerena Montanari, Marco Allarà, Laura Scalvini, et al.International Journal of Molecular Sciences|September 16, 2014
Synthesis and characterization of new bivalent agents as melatonin- and histamine H3-ligandsDaniele Pala, Laura Scalvini, Alessio Lodola, et al.ACS Omega|January 5, 2022
Phenotype Screening of an Azole-bisindole Chemical Library Identifies URB1483 as a New Antileishmanial Agent Devoid of Toxicity on Human CellsAurora Diotallevi, Laura Scalvini, Gloria Buffi, et al.Journal of Pineal Research|April 12, 2024
Binding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidenceAnnalida Bedini, Gian Marco Elisi, Fabiola Fanini, et al.Journal of Medicinal Chemistry|June 17, 2016
Fatty Acid Amide Hydrolase (FAAH), Acetylcholinesterase (AChE), and Butyrylcholinesterase (BuChE): Networked Targets for the Development of Carbamates as Potential Anti-Alzheimer's Disease AgentsSerena Montanari, Laura Scalvini, Manuela Bartolini, et al.European Journal of Medicinal Chemistry|January 31, 2020
Optimization of EphA2 antagonists based on a lithocholic acid core led to the identification of UniPR505, a new 3α-carbamoyloxy derivative with antiangiogenetic propertiesMatteo Incerti, Simonetta Russo, Miriam Corrado, et al.Journal of Medicinal Chemistry|March 30, 2018
Tetrahydroquinoline Ring as a Versatile Bioisostere of Tetralin for Melatonin Receptor LigandsSilvia Rivara, Laura Scalvini, Alessio Lodola, et al.Journal of Chemical Information and Modeling|November 1, 2023
Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved SelectivityLorenzo Guidetti, Alfonso Zappia, Laura Scalvini, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|September 10, 2020
New classes of potent heparanase inhibitors from ligand-based virtual screeningDaniele Pala, Laura Scalvini, Gian Marco Elisi, et al.European Journal of Medicinal Chemistry|August 31, 2021
A sulfonyl fluoride derivative inhibits EGFR<sup>L858R/T790M/C797S</sup> by covalent modification of the catalytic lysineFrancesca Ferlenghi, Laura Scalvini, Federica Vacondio, et al.Pageof 5